- Human immune repertoire in hepatitis B virus infection
Qiao Zhan et al, 2021, World Journal of Gastroenterology CrossRef - Intrahepatic TH17/TReg Cells in Homeostasis and Disease—It’s All About the Balance
Hannah K. Drescher et al, 2020, Frontiers in Pharmacology CrossRef - Recovery of host adaptive immune function promoted the reduction of hepatitis B surface antigen in nucleoside analog-experienced chronic hepatitis B patients with low hepatitis B surface antigen levels
Qian Zhang et al, 2023, Cytokine CrossRef - The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV?
Lauke L Boeijen et al, 2020, Antiviral Therapy CrossRef - Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
Wen-Jie Wang et al, 2020, Frontiers in Genetics CrossRef - Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection
Chih‐Wei Tseng et al, 2020, Journal of Viral Hepatitis CrossRef - Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion
Meng-Lan Wang et al, 2016, Viral Immunology CrossRef - Immune Regulation by T Regulatory Cells in Hepatitis B Virus‐Related Inflammation and Cancer
N. Trehanpati et al, 2017, Scandinavian Journal of Immunology CrossRef - The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4+CD25+ regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment
Jiezuan Yang et al, 2016, Cellular & Molecular Immunology CrossRef - Effect of WSP, a Chinese Herbal Formula, on Th17/Treg Ratio and HBeAg Seroconversion in Telbivudine-Treated HBeAg-Positive Chronic Hepatitis B Patients with High Baseline ALT Levels (20–30 Times the ULN)
Yang Zhang et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef - Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients
X Pang et al, 2020, Clinical and Experimental Immunology CrossRef